Article

New microincision surgery system earns high marks

A new microincision cataract surgery system (Stellaris Vision Enhancement System, Bausch & Lomb) is a flexible system designed to support rapidly evolving trends in microincision surgery. A full range of ancillary instruments is provided and designed to reduce the learning curve for surgeons.

Key Points

San Diego-A new microincision cataract surgery system ([MICS]; Stellaris Vision Enhancement System, Bausch & Lomb), has earned high marks for its performance during all phases of phacoemulsification procedures in a field observation study.

During the field observation study, Drs. Davis and Devine subjectively assessed the system's performance during procedures and rated it as acceptable or not acceptable, not applicable, yes or no, and used a scale of 1 to 5, wherein 1 indicated excellent and 5 indicated very poor, Dr. Davis explained. She is a partner, Minnesota Eye Consultants, and adjunct clinical assistant professor, University of Minnesota, Minneapolis.

"The system availability without interruption throughout the entire procedure was rated acceptable," Dr. Davis said. "The absolute phaco time was most often 0 seconds and less than 3 seconds for 3 to 4+ cataracts. There were no adverse events associated with the use of the system."

She said that her current standard vacuum-based microcoaxial technique on the new MICS is a supracapsular approach with chopping. The technique consists of prolapsing one pole of the nucleus into the anterior chamber above the capsulorhexis to reduce zonular stress. The tilted pole is supported with a second instrument. Lens manipulation and emulsification are done in the iris plane, which reduces risk of capsular tear and helps with visualization if the pupil constricts.

The linear power ranges from 0% to 4%, and the linear vacuum ranges from 200 to 600 mm Hg. Advanced fluidics keep the anterior chamber stable.

Features

The feature of the system that probably is most advantageous for surgeons is the next-generation fluidics management system (EQ Fluidics), which aims to provide equal or balanced control of flow and aspiration, Dr. Davis said. Options include flow with vacuum characteristics and vacuum with proprietary outflow tubing (StableChamber).

The fluidics system includes a six-crystal, 2.8-kHz ultrasound handpiece designed to be ergonomic; power modulation software (CustomControl II); wireless dual linear technology; a touch screen display designed to be intuitive; streaming video inlay; and a modular design platform. The all-electric drive aims to make the system more convenient in terms of space, cost, and ease of handling without affecting overall vacuum responsiveness. The increase from four to six crystals is an effort to enable the handpiece to be narrower, more compact, and better balanced for increased comfort.

"The kilohertz rate is the same as that of the [predecessor] system. The main difference is the stroke length that translates into better cutting efficiency. Tests are currently under way," Dr. Davis said.

"All competitive handpieces are at higher rates-40 kHz," she added, mentioning that one in particular (OZil, Alcon Laboratories) alternates between 40 kHz for the jackhammer and 32 kHz for the torsional part.

"Mark Shafer, PhD, has published extensively on the merits of optimized action under 30 kHz and is currently performing tests with the [new] handpiece," Dr. Davis said.

The flow module has a single-use, pre-connected cartridge and a single-use, pre-connected 300-ml cassette. The module enables precise detection of fluid levels.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.